The cancellation or postponement of procedures due to the COVID-19 pandemic will have a significant negative impact on the Latin American market for aesthetic injectables in the short term. Once the situation improves, however, the market will resume strong growth, driven by high levels of aesthetic consciousness, marketing efforts from the major players, and an expanding patient pool.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for aesthetic injectables in Latin America across a 10-year period.​


The emergence of COVID-19 is affecting the aesthetic injectable market in the short term.

How will COVID-19 affect procedure volumes?

What will be the impact on market dynamics?

What strategies can companies use to remain successful in this market?

The dermal filler market has a greater revenue share in the Latin American aesthetic injectable market.

What are the drivers and limiters of the aesthetic injectable market?

What is the variation across procedure shares and revenue shares for dermal filler and BTX market?

Large MNCs will maintain their dominant positions in the market over the forecast period.

How do the most established competitors in this market maintain market share?

What strategies can new competitors employ to gain entry into the Latin American aesthetic injectable market?

Table of contents

  • Latin America
    • Abstract
    • Executive Summary
      • COVID-19 Updates
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Geographies Covered
      • Procedures and Products Covered
    • Key Report Updates
    • COVID-19 Analysis
      • Market Impact
      • Guidance and Recommendations
      • Industry and Clinician Perspectives
      • Major Market Forecast Changes and Assumptions
      • Competitive Impact
    • Aesthetic Injectable Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
        • Physician Training and Marketing
        • First-Mover Advantage
        • Product Portfolio Management
        • Mergers, Acquisitions, and Partnerships
        • Clinical Data
        • Pricing Strategies and Purchasing Options
        • Distribution and Sales Network
        • Patient Marketing and Awareness
      • Market Developments
    • Botulinum Toxin Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
        • Physician Training and Marketing
        • Mergers, Acquisitions, and Partnerships
        • Distribution and Sales Network
    • Dermal Filler Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Country
        • By Material
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
        • Physician Training and Marketing
        • Product Portfolio Management
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Meenu Sankar, MS

Meenu Sankar is a research associate within the Orthopedics, Dental, and Aesthetics Medtech Insights team at DRG (Part of Clarivate), specializing in large-joint reconstructive implants. Meenu holds a Bachelor's degree in Pharmaceutical Sciences from Manipal University and a Master's degree in Biomedicine from The University of Skövde. Follow Meenu on Twitter:@meenu_sankarDRG


Related Reports

Aesthetic Injectables | Medtech 360 | Market Insights | Asia Pacific

The COVID-19 pandemic will have a significant impact on the Asia Pacific aesthetic injectable market in the short term. Once the market st...

View Details

Aesthetic Injectables | Medtech 360 | Market Insights | Europe (Supplemental)

The European aesthetic injectable market will grow rapidly through 2028, driven by increasing penetration into new patient groups, such as men and younger patients, major...

View Details

Aesthetic Injectables | Medtech 360 | Market Insights | United States

The US market for aesthetic injectables will continue to grow through 2028, driven primarily by high patient demand, including from emerging patient groups such as men and younger individuals. N...

View Details

Aesthetic Injectables | Medtech 360 | Market Insights | Europe

The European aesthetic injectables market will grow rapidly through 2028, driven by increasing penetration into new patient groups, such as men and younger patients, as well as...

View Details